Kirsten R. Müller-Vahl is a specialist in neurology and psychiatry and senior physician at the Department of Psychiatry, Social Psychiatry and Psychotherapy at the Hannover Medical School (MHH) and leads there the "Tourette's Research Group" .
She is the 1. chairwoman of the "Arbeitsgemeinschaft Cannabis als Medizin" and the "International Alliance for Cannabis as Medicine" (IACM) as well as member of the expert committee for narcotics of the Federal Opium Agency of the Federal Institute for Drugs and Medical Devices (BfArM).
She was an individual expert in the Committee on Health of the German Bundestag for the hearing on the draft law amending narcotics regulations on the marketability and prescribability of additional cannabis medicinal products.
In 2017, she received the “IACM Award for Clinical Research for her special achievements regarding the re-introduction of cannabis and cannabinoids as medicine”.
She is the principal investigator in numerous DFG, BMBF, EU and industry funded studies, including cannabis-based medicines and cannabinoid modulators, has more than 160 scientific articles and numerous book chapters and is co-editor of the standard work on cannabis as medicine: Müller-Vahl KR, Grotenhermen F (Hrg). Cannabis als Medizin, Berlin: MWV Medizinisch Wissenschaftliche Verlagsgesellschaft; 2020. ISBN: 978-3-95466-509-9. She is editor or member of the editorial board of the journals "Cannabis and Cannabinoid Research" and "Medical Cannabis and Cannabinoids".